Impact of Paroxysmal Supraventricular Tachycardia on Quality of Life: An Observational Study.

Contenuto principale dell'articolo

Giuseppe Ruffino
Giorgio Bergesio
Carmen Samà
Simona Fantauzzi

Abstract

INTRODUCTION


Paroxysmal Supraventricular Tachycardia (PSVT) is a common arrhythmia that can occur at any age. On the electrocardiogram, it presents as a narrow QRS complex with a heart rate greater than 120 beats per minute. Signs and symptoms include palpitations, dizziness, chest pain, and other symptoms. The purpose of the study is to evaluate the Quality of Life (QoL) in people with PSVT.


MATERIALS AND METHODS


An observational study was conducted between February and July 2024 on a sample of 202 patients with TPSV. The UMEA22 (U22) and Medical Outcomes Study 36-Item Short Form Healthy Survey 36 (SF-36) scales were used. Statistical analyses were conducted with Jamovi®.


Correlations between variables were examined using Pearson's r, and Welch's ANOVA with a Games-Howell post-hoc test was used to evaluate comparisons between groups, with a significance level of alpha = 0.05.


RESULTS


On the U22 scale, patients reported an average score of 7.95 for general health and 8.65 for the impact of symptoms on psychological and physical well-being. The SF-36 scale had average scores of 85.0 for physical health and 73.3 for mental health.


Significant differences emerged between males and females. Physical activity is associated with better mental and physical health. Ablation was significantly associated with improved physical and mental health.


CONCLUSION  


The study provides important insights into how sociodemographic and behavioral variables influence patients' quality of life. Significant differences were found related to gender, age, and occupation. Personalized interventions that take into account differences in gender, age, socioeconomic status, and physical activity levels could significantly improve patient well-being.

Downloads

I dati di download non sono ancora disponibili.

Dettagli dell'articolo

Come citare
Ruffino, G., Bergesio, G., Samà, C., & Fantauzzi, S. (2025). Impact of Paroxysmal Supraventricular Tachycardia on Quality of Life: An Observational Study. Journal of Biomedical Practitioners, 9(2). https://doi.org/10.13135/2532-7925/13003
Sezione
Scienze infermieristiche

Riferimenti bibliografici

[1] Ferguson JD, DiMarco JP. Contemporary management of paroxysmal supraventricular tachycardia. Circulation. 2003; 107(8):1096-9.

[2] Peng G, Zei PC. Diagnosis and Management of Paroxysmal Supraventricular Tachycardia. JAMA. 2024; 331(7):601-10.

[3] Bathina MN, Mickelsen S, Brooks C, Jaramillo J, Hepton T, Kusumoto FM. Radiofrequency catheter ablation versus medical therapy for initial treatment of supraventricular tachycardia and its impact on quality of life and healthcare costs. Am J Cardiol. 1998; 82(5):589-93.

[4] Kesek M, Rönn F, Tollefsen T, Höglund N, Näslund U, Jensen SM. Symptomatic improvement after catheter ablation of supraventricular tachycardia measured by the arrhythmia-specific questionnaire U22. Ups J Med Sci. 2011; 116(1):52-9.

[5] Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item se-lection. Med Care. 1992; 30(6):473-83

[6] Tian XT, Xu YJ, Yang YQ. Gender Differences in Arrhythmias: Focused on Atrial Fibrillation. J Cardiovasc Transl Res. 2020; 13(1):85-9.

[7] Go AS, Hlatky MA, Liu TI, Fan D, Garcia EA, Sung SH, Solomon MD. Contemporary Burden and Correlates of Sympto-matic Paroxysmal Supraventricular Tachycardia. J Am Heart Assoc. 2018; 7(14):E008759.

[8] Carnlöf, Carina, et al. Women with PSVT are often misdiagnosed, referred later than men, and have more symptoms after ablation. Scandinavian Cardiovascular Journal 2017; 51(6): 299-307.

[9] Lu J, Yu Z, Zhang X, Wu M, Lin S, Zhu Y, Xu Z, You L, Wei F, Tang M, Jin M, Wang J, Chen K. Association between social health status and health-related quality of life among community-dwelling elderly in Zhejiang. Health Qual Life Outcomes. 2020; 18(1):110.

[10] Paul Karsten I., Klaus Moser. Unemployment impairs mental health: Meta-analyses. Journal of Vocational behaviour. 2009; 74.3: 264-82.

[11] Butterworth, P., Leach, L. S., Strazdins, L., Olesen, S. C., Rodgers, B., & Broom, D. H. The psychosocial quality of work determines whether employment has benefits for mental health: results from a longitudinal national household panel survey. Occupational and environmental medicine. 2011; 68(11), 806–12.

[12] Franklin BA, Lavie CJ, Squires RW, Milani RV. Exercise-based cardiac rehabilitation and improvements in cardiorespira-tory fitness: implications regarding patient benefit. Mayo Clin Proc. 2013; 88(5):431-7.

[13] Lavie CJ, Arena R, Swift DL, et al. Exercise and the cardiovascular system: clinical science and cardiovascular out-comes. Circ Res. 2015; 117(2):207-219.

[14] Fiuza-Luces C, Santos-Lozano A, Joyner M, et al. Exercise benefits in cardiovascular disease: beyond attenuation of traditional risk factors. Nat Rev Cardiol. 2018; 15(12):731-43.

[15] Kesek, M., Tollefsen, T., Höglund, N., Rönn, F., Näslund, U., & Jensen, S. M. U22, a protocol to quantify symptoms associated with supraventricular tachycardia. Pacing and Clinical Electrophysiology, 2009; 32, 105-8.

[16] Höglund N, Rönn F, Tollefsen T, Jensen SM, Kesek M. U22 protocol as measure of symptomatic improvement after catheter ablation of atrial fibrillation. Ups J Med Sci. 2013; 118(4):240-6.

[17] Wood KA, Wiener CL, Kayser-Jones J. Supraventricular tachycardia and the struggle to be believed. Eur J Cardiovasc Nurs. 2007; 6(4):293-302